Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.87 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Stifel Healthcare Conference Transcript

Nov 20, 2019 / 03:55PM GMT
Release Date Price: $27.73 (-1.70%)
Annabel Eva Samimy
Stifel, Nicolaus & Company, Incorporated, Research Division - MD

Good morning, everyone, and welcome to the Bausch Health presentation. It's our pleasure to have CEO Joe Papa here with us who, I think, has orchestrated probably one of a tremendous feat, I would say from 3 years ago. And it's fair to say that Bausch is in a relatively stable position right now. I think you've got probably 75% to 80% of your revenues in a growth phase -- in a state of growth as opposed to a state of decline. Obviously, there's still a couple of areas of work to do. So obviously, that's getting dermatology back on track and getting the leverage back to a much more reasonable level. But you are well on your way.

So why don't I let you take a few minutes, give everyone a lay of the land, and then we can just launch into Q&A.

Joseph C. Papa
Bausch Health Companies Inc. - CEO & Chairman of the Board

Sure. So it's a pleasure to be here with everyone. It's a chance to talk about some of the things that we've been working very hard at Bausch

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot